|Bid||0.4450 x N/A|
|Ask||0.4550 x N/A|
|Day's Range||0.4400 - 0.4550|
|52 Week Range||0.4400 - 2.6300|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 22, 2022 - Aug 26, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.01|
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company") a company focused on transforming healthcare through digital health software solutions is pleased to announce that it has been contracted by a major U.S.-based pharmacy to deliver business intelligence and support solutions to more than 1700 pharmacies servicing 5.5 million patients throughout the United States. This contract is a direct result of the acquisition and subsequent integration of Pharmapod Ltd. ("Pharm
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a healthcare technology company focused on transforming healthcare through knowledge-based digital health software solutions, announced today that it has amended its existing advisory services agreement (the "Amended Services Agreement") with Oak Hill Financial Inc. ("Oak Hill"), following receipt of conditional approval of the TSX Venture Exchange ("TSXV").
Think Research Corporation (TSXV: THNK) (OTCQB: THKKF) ("Think" or the "Company"), a company focused on transforming healthcare through integrated digital health software solutions, today announced that it has granted 261,955 restricted share units (each, an "RSU") to key employees of the Company pursuant to the Company's Omnibus Equity Incentive Plan which will vest immediately.